Drawing for NORMAXAN

USPTO serial 79001356

NORMAXAN

Reviewed by CopyMark Law Group

Reg. 3073673Status 404
Filing date
Status date
Registration date
Mar 28, 2006
Examiner
SINGH, TEJBIR
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NORMAXAN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Anti-depressive pharmaceutical preparationsSECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 6, 2013UNDRUNDELIVERABLE MAIL - CORRESP. REMAILED
Apr 28, 2013DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Apr 28, 2013DETHDEATH OF INTERNATIONAL REGISTRATION
Nov 2, 2012C71TCANCELLED SECTION 71
Dec 4, 2011ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 2, 2007FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Nov 10, 2006ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 10, 2006REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 25, 2006FICSFINAL DISPOSITION NOTICE SENT TO IB
Oct 25, 2006FIMPFINAL DISPOSITION PROCESSED
Oct 19, 2006FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 28, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 3, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 14, 2005NPUBNOTICE OF PUBLICATION
Nov 16, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 4, 2005ALIEASSIGNED TO LIE
Nov 3, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Oct 29, 2005RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sep 30, 2005OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 1, 2005OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 1, 2005OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 11, 2005DOCKASSIGNED TO EXAMINER
Apr 4, 2005CNSLLETTER OF SUSPENSION MAILED
Apr 1, 2005CNSLSUSPENSION LETTER WRITTEN
Apr 1, 2005ACECAMENDMENT FROM APPLICANT ENTERED
Mar 21, 2005MAILPAPER RECEIVED
Mar 14, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 7, 2004RFNTREFUSAL PROCESSED BY IB
Sep 14, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 9, 2004CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 9, 2004DOCKASSIGNED TO EXAMINER
Apr 13, 2004NWAPNEW APPLICATION ENTERED
Apr 8, 2004SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Frequently asked questions

Related guidance